The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Abbott Laboratories (NYSE:ABT) ...

Abbott Laboratories’ modelled fair value has been adjusted only fractionally, from US$133.39 to US$133.33 per share, keeping the core price target effectively stable in absolute terms. That tiny shift ...

Attorneys for parents and Abbott Laboratories faced off during opening arguments Monday in the first Chicago trial over ...

The latest chapter in an ongoing legal battle between Abbott Laboratories and parents of babies born prematurely is slated to ...

Exact Sciences Corp. (NASDAQ:EXAS) is one of 15 stocks with the biggest hedge fund momentum, after gaining 31 hedge fund holders during the fourth quarter of 2025. On February 20, the company ...

"Boring" may be just what the doctor ordered in this volatile market.

Jury selection in Cook County is set to kick off this week in a closely watched courtroom battle over Abbott Laboratories’ ...

Abbott stock skidded Wednesday after the S&P 500 health giant missed the Street's third-quarter sales forecast, but met earnings expectations and reiterated its full-year guidance. The sales miss is ...

Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that's been weighed down by ongoing litigation for several months.

The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter, Abbott ...

The stock's fall snapped a three-day winning streak.

C.H. Unnikrishnan US drug maker Abbott Laboratories, which invested at least Rs 25,600 crore ($4 billion) in India in the last five years including the acquisition of domestic drug formulation ...